299 related articles for article (PubMed ID: 23955597)
1. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.
Chubb D; Weinhold N; Broderick P; Chen B; Johnson DC; Försti A; Vijayakrishnan J; Migliorini G; Dobbins SE; Holroyd A; Hose D; Walker BA; Davies FE; Gregory WA; Jackson GH; Irving JA; Pratt G; Fegan C; Fenton JA; Neben K; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Ross FM; Straka C; Einsele H; Langer C; Dörner E; Allan JM; Jauch A; Morgan GJ; Hemminki K; Houlston RS; Goldschmidt H
Nat Genet; 2013 Oct; 45(10):1221-1225. PubMed ID: 23955597
[TBL] [Abstract][Full Text] [Related]
2. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.
Weinhold N; Johnson DC; Rawstron AC; Försti A; Doughty C; Vijayakrishnan J; Broderick P; Dahir NB; Begum DB; Hosking FJ; Yong K; Walker BA; Hoffmann P; Mühleisen TW; Langer C; Dörner E; Jöckel KH; Eisele L; Nöthen MM; Hose D; Davies FE; Goldschmidt H; Morgan GJ; Hemminki K; Houlston RS
Blood; 2014 Apr; 123(16):2513-7; quiz 2593. PubMed ID: 24449210
[TBL] [Abstract][Full Text] [Related]
3. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.
Rand KA; Song C; Dean E; Serie DJ; Curtin K; Sheng X; Hu D; Huff CA; Bernal-Mizrachi L; Tomasson MH; Ailawadhi S; Singhal S; Pawlish K; Peters ES; Bock CH; Stram A; Van Den Berg DJ; Edlund CK; Conti DV; Zimmerman T; Hwang AE; Huntsman S; Graff J; Nooka A; Kong Y; Pregja SL; Berndt SI; Blot WJ; Carpten J; Casey G; Chu L; Diver WR; Stevens VL; Lieber MR; Goodman PJ; Hennis AJ; Hsing AW; Mehta J; Kittles RA; Kolb S; Klein EA; Leske C; Murphy AB; Nemesure B; Neslund-Dudas C; Strom SS; Vij R; Rybicki BA; Stanford JL; Signorello LB; Witte JS; Ambrosone CB; Bhatti P; John EM; Bernstein L; Zheng W; Olshan AF; Hu JJ; Ziegler RG; Nyante SJ; Bandera EV; Birmann BM; Ingles SA; Press MF; Atanackovic D; Glenn MJ; Cannon-Albright LA; Jones B; Tricot G; Martin TG; Kumar SK; Wolf JL; Deming Halverson SL; Rothman N; Brooks-Wilson AR; Rajkumar SV; Kolonel LN; Chanock SJ; Slager SL; Severson RK; Janakiraman N; Terebelo HR; Brown EE; De Roos AJ; Mohrbacher AF; Colditz GA; Giles GG; Spinelli JJ; Chiu BC; Munshi NC; Anderson KC; Levy J; Zonder JA; Orlowski RZ; Lonial S; Camp NJ; Vachon CM; Ziv E; Stram DO; Hazelett DJ; Haiman CA; Cozen W
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1609-1618. PubMed ID: 27587788
[TBL] [Abstract][Full Text] [Related]
4. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.
Broderick P; Chubb D; Johnson DC; Weinhold N; Försti A; Lloyd A; Olver B; Ma Y; Dobbins SE; Walker BA; Davies FE; Gregory WA; Childs JA; Ross FM; Jackson GH; Neben K; Jauch A; Hoffmann P; Mühleisen TW; Nöthen MM; Moebus S; Tomlinson IP; Goldschmidt H; Hemminki K; Morgan GJ; Houlston RS
Nat Genet; 2011 Nov; 44(1):58-61. PubMed ID: 22120009
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
Speedy HE; Di Bernardo MC; Sava GP; Dyer MJ; Holroyd A; Wang Y; Sunter NJ; Mansouri L; Juliusson G; Smedby KE; Roos G; Jayne S; Majid A; Dearden C; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Rosenquist R; Catovsky D; Allan JM; Houlston RS
Nat Genet; 2014 Jan; 46(1):56-60. PubMed ID: 24292274
[TBL] [Abstract][Full Text] [Related]
6. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.
Crowther-Swanepoel D; Broderick P; Di Bernardo MC; Dobbins SE; Torres M; Mansouri M; Ruiz-Ponte C; Enjuanes A; Rosenquist R; Carracedo A; Jurlander J; Campo E; Juliusson G; Montserrat E; Smedby KE; Dyer MJ; Matutes E; Dearden C; Sunter NJ; Hall AG; Mainou-Fowler T; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Bailey JR; Pratt G; Pepper C; Fegan C; Parker A; Oscier D; Allan JM; Catovsky D; Houlston RS
Nat Genet; 2010 Feb; 42(2):132-6. PubMed ID: 20062064
[TBL] [Abstract][Full Text] [Related]
7. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.
Campa D; Martino A; Sainz J; Buda G; Jamroziak K; Weinhold N; Vieira Reis RM; García-Sanz R; Jurado M; Ríos R; Szemraj-Rogucka Z; Marques H; Lesueur F; Bugert P; Moreno V; Szemraj J; Orciuolo E; Gemignani F; Rossi AM; Dumontet C; Petrini M; Goldschmidt H; Landi S; Canzian F
Br J Haematol; 2012 May; 157(3):331-8. PubMed ID: 22590720
[TBL] [Abstract][Full Text] [Related]
9. Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Macauda A; Clay-Gilmour A; Hielscher T; Hildebrandt MAT; Kruszewski M; Orlowski RZ; Kumar SK; Ziv E; Orciuolo E; Brown EE; Försti A; Waller RG; Machiela MJ; Chanock SJ; Camp NJ; Rymko M; Raźny M; Cozen W; Várkonyi J; Piredda C; Pelosini M; Belachew AA; Subocz E; Hemminki K; Rybicka-Ramos M; Giles GG; Milne RL; Hofmann JN; Zaucha JM; Vangsted AJ; Goldschmidt H; Rajkumar SV; Tomczak W; Sainz J; Butrym A; Watek M; Iskierka-Jazdzewska E; Buda G; Robinson DP; Jurczyszyn A; Dudziński M; Martinez-Lopez J; Sinnwell JP; Slager SL; Jamroziak K; Reis RMV; Weinhold N; Bhatti P; Carvajal-Carmona LG; Zawirska D; Norman AD; Mazur G; Berndt SI; Campa D; Vachon CM; Canzian F
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1863-1866. PubMed ID: 35700034
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition for multiple myeloma.
Pertesi M; Went M; Hansson M; Hemminki K; Houlston RS; Nilsson B
Leukemia; 2020 Mar; 34(3):697-708. PubMed ID: 31913320
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.
Mitchell JS; Li N; Weinhold N; Försti A; Ali M; van Duin M; Thorleifsson G; Johnson DC; Chen B; Halvarsson BM; Gudbjartsson DF; Kuiper R; Stephens OW; Bertsch U; Broderick P; Campo C; Einsele H; Gregory WA; Gullberg U; Henrion M; Hillengass J; Hoffmann P; Jackson GH; Johnsson E; Jöud M; Kristinsson SY; Lenhoff S; Lenive O; Mellqvist UH; Migliorini G; Nahi H; Nelander S; Nickel J; Nöthen MM; Rafnar T; Ross FM; da Silva Filho MI; Swaminathan B; Thomsen H; Turesson I; Vangsted A; Vogel U; Waage A; Walker BA; Wihlborg AK; Broyl A; Davies FE; Thorsteinsdottir U; Langer C; Hansson M; Kaiser M; Sonneveld P; Stefansson K; Morgan GJ; Goldschmidt H; Hemminki K; Nilsson B; Houlston RS
Nat Commun; 2016 Jul; 7():12050. PubMed ID: 27363682
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33.
Houlston RS; Cheadle J; Dobbins SE; Tenesa A; Jones AM; Howarth K; Spain SL; Broderick P; Domingo E; Farrington S; Prendergast JG; Pittman AM; Theodoratou E; Smith CG; Olver B; Walther A; Barnetson RA; Churchman M; Jaeger EE; Penegar S; Barclay E; Martin L; Gorman M; Mager R; Johnstone E; Midgley R; Niittymäki I; Tuupanen S; Colley J; Idziaszczyk S; ; Thomas HJ; Lucassen AM; Evans DG; Maher ER; ; ; ; Maughan T; Dimas A; Dermitzakis E; Cazier JB; Aaltonen LA; Pharoah P; Kerr DJ; Carvajal-Carmona LG; Campbell H; Dunlop MG; Tomlinson IP
Nat Genet; 2010 Nov; 42(11):973-7. PubMed ID: 20972440
[TBL] [Abstract][Full Text] [Related]
13. Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes.
Waller RG; Klein RJ; Vijai J; McKay JD; Clay-Gilmour A; Wei X; Madsen MJ; Sborov DW; Curtin K; Slager SL; Offit K; Vachon CM; Lipkin SM; Dumontet C; Camp NJ
Hum Mol Genet; 2021 Jun; 30(12):1142-1153. PubMed ID: 33751038
[TBL] [Abstract][Full Text] [Related]
14. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma.
Went M; Sud A; Försti A; Halvarsson BM; Weinhold N; Kimber S; van Duin M; Thorleifsson G; Holroyd A; Johnson DC; Li N; Orlando G; Law PJ; Ali M; Chen B; Mitchell JS; Gudbjartsson DF; Kuiper R; Stephens OW; Bertsch U; Broderick P; Campo C; Bandapalli OR; Einsele H; Gregory WA; Gullberg U; Hillengass J; Hoffmann P; Jackson GH; Jöckel KH; Johnsson E; Kristinsson SY; Mellqvist UH; Nahi H; Easton D; Pharoah P; Dunning A; Peto J; Canzian F; Swerdlow A; Eeles RA; Kote-Jarai Z; Muir K; Pashayan N; Nickel J; Nöthen MM; Rafnar T; Ross FM; da Silva Filho MI; Thomsen H; Turesson I; Vangsted A; Andersen NF; Waage A; Walker BA; Wihlborg AK; Broyl A; Davies FE; Thorsteinsdottir U; Langer C; Hansson M; Goldschmidt H; Kaiser M; Sonneveld P; Stefansson K; Morgan GJ; Hemminki K; Nilsson B; Houlston RS;
Nat Commun; 2018 Sep; 9(1):3707. PubMed ID: 30213928
[TBL] [Abstract][Full Text] [Related]
15. [Chromosome anomalies in Venezuelan patients with multiple myeloma].
Quintero M; Rojas-Atencio A; Ruiz A; González M; Herrera J; Atencio F; Delgado W; Urdaneta K; Pérez F
Invest Clin; 2003 Dec; 44(4):327-35. PubMed ID: 14727386
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia.
Law PJ; Berndt SI; Speedy HE; Camp NJ; Sava GP; Skibola CF; Holroyd A; Joseph V; Sunter NJ; Nieters A; Bea S; Monnereau A; Martin-Garcia D; Goldin LR; Clot G; Teras LR; Quintela I; Birmann BM; Jayne S; Cozen W; Majid A; Smedby KE; Lan Q; Dearden C; Brooks-Wilson AR; Hall AG; Purdue MP; Mainou-Fowler T; Vajdic CM; Jackson GH; Cocco P; Marr H; Zhang Y; Zheng T; Giles GG; Lawrence C; Call TG; Liebow M; Melbye M; Glimelius B; Mansouri L; Glenn M; Curtin K; Diver WR; Link BK; Conde L; Bracci PM; Holly EA; Jackson RD; Tinker LF; Benavente Y; Boffetta P; Brennan P; Maynadie M; McKay J; Albanes D; Weinstein S; Wang Z; Caporaso NE; Morton LM; Severson RK; Riboli E; Vineis P; Vermeulen RC; Southey MC; Milne RL; Clavel J; Topka S; Spinelli JJ; Kraft P; Ennas MG; Summerfield G; Ferri GM; Harris RJ; Miligi L; Pettitt AR; North KE; Allsup DJ; Fraumeni JF; Bailey JR; Offit K; Pratt G; Hjalgrim H; Pepper C; Chanock SJ; Fegan C; Rosenquist R; de Sanjose S; Carracedo A; Dyer MJ; Catovsky D; Campo E; Cerhan JR; Allan JM; Rothman N; Houlston R; Slager S
Nat Commun; 2017 Feb; 8():14175. PubMed ID: 28165464
[TBL] [Abstract][Full Text] [Related]
17. Do myeloproliferative neoplasms and multiple myeloma share the same genetic susceptibility loci?
Macauda A; Giaccherini M; Sainz J; Gemignani F; Sgherza N; Sánchez-Maldonado JM; Gora-Tybor J; Martinez-Lopez J; Carreño-Tarragona G; Jerez A; Spadano R; Gołos A; Jurado M; Hernández-Mohedo F; Mazur G; Tavano F; Butrym A; Várkonyi J; Canzian F; Campa D
Int J Cancer; 2021 Apr; 148(7):1616-1624. PubMed ID: 33038278
[TBL] [Abstract][Full Text] [Related]
18. Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism.
Li N; Johnson DC; Weinhold N; Kimber S; Dobbins SE; Mitchell JS; Kinnersley B; Sud A; Law PJ; Orlando G; Scales M; Wardell CP; Försti A; Hoang PH; Went M; Holroyd A; Hariri F; Pastinen T; Meissner T; Goldschmidt H; Hemminki K; Morgan GJ; Kaiser M; Houlston RS
Cell Rep; 2017 Sep; 20(11):2556-2564. PubMed ID: 28903037
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
Law PJ; Sud A; Mitchell JS; Henrion M; Orlando G; Lenive O; Broderick P; Speedy HE; Johnson DC; Kaiser M; Weinhold N; Cooke R; Sunter NJ; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Carmichael J; Bailey JR; Pratt G; Rahman T; Pepper C; Fegan C; von Strandmann EP; Engert A; Försti A; Chen B; Filho MI; Thomsen H; Hoffmann P; Noethen MM; Eisele L; Jöckel KH; Allan JM; Swerdlow AJ; Goldschmidt H; Catovsky D; Morgan GJ; Hemminki K; Houlston RS
Sci Rep; 2017 Jan; 7():41071. PubMed ID: 28112199
[TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of multiple myeloma risk within the Wnt/beta-catenin signaling pathway.
Belachew AA; Wu X; Callender R; Waller R; Orlowski RZ; Vachon CM; Camp NJ; Ziv E; Hildebrandt MAT
Cancer Epidemiol; 2021 Aug; 73():101972. PubMed ID: 34216957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
